• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number PIPELINE
Device Problems Migration or Expulsion of Device (1395); Inadequacy of Device Shape and/or Size (1583)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/11/2011
Event Type  malfunction  
Event Description
Citation: lubicz et al.Pipeline flow-diverter stent for endovascular treatment of intracranial aneurysms: preliminary experience in 20 patients with 27 aneurysms.World neurosurgery (2011) 76, 1/2:114-119.Medtronic (covidien) received information through literature review that there were technical issues in pipeline delivery including stent migration, stent misplacement, unanticipated stent shortening, and the impossibility to recapture the distal coil tip of the supporting device.It was reported that the author study a population of 20 patients (mean age 49, 14 females) with 27 fusiform or wide-necked aneurysms that were treated with pipeline embolization device (ped).Tha author reported that in 7 out of 27 cases the coil tip remained stuck at the distal tip of the delivery catheter and could not be resheathed despite the use of a dedicated torque.No stent dislodgment occurred during these manipulations.No patient injury was reported as a result of the procedure.
 
Manufacturer Narrative
(b)(4).The lot history record review was not possible since the lot numbers were not reported.The devices will not be returned for analysis as they were implanted in the patient; therefore, the event cause could not be determined.The authors stated that the stent shortening and migration may happen due to inappropriate device size and length selection because they "always choose a stent diameter 0.25-0.5mm larger than the distal parent artery diameter and longer length to ensure good stability." the instruction for use indicated, "select an appropriately sized ped such that it is fully expanded diameter is equivalent to that of the largest target vessel diameter.An incorrectly sized ped may result in inadequate device placement, incomplete opening, or distal migration." (b)(4).Death from the same article was reported in mdr mfr# 2029214-2015-00241.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key4587747
MDR Text Key5335966
Report Number2029214-2015-00241
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
P100018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 02/24/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/10/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberPIPELINE
Device Catalogue NumberPIPELINE
Device Lot NumberNOT REPORTED
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/24/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age49 YR
-
-